Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

NCT00677612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Lack of financial support

Conditions

Colorectal Cancer
Colon Cancer
Rectal Cancer

Interventions

BIOLOGICAL: VEGFR1 and VEGFR2

Sponsor

Tokyo University

Collaborators

[object Object]